Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to HIV-1-infection
Related studies linked through entity extraction aliases.
Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA®
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pharmacokinetic Interactions of ENG Subdermal Implants with Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA)
- Status
- WITHDRAWN
- Phase
- PHASE4
Long-Acting Treatment in Adolescents (LATA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age
- Status
- UNKNOWN
- Phase
- PHASE4
Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART
- Status
- COMPLETED
- Phase
- PHASE1
Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Supporting Treatment Adherence for Resilience and Thriving (START)
- Status
- COMPLETED
- Phase
- NA
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
- Status
- RECRUITING
- Phase
- NA
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
- Status
- RECRUITING
- Phase
- N/A
Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Implementing Cabenuva in Arkansas HIV Programs
- Status
- TERMINATED
- Phase
- NA
SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort
- Status
- COMPLETED
- Phase
- N/A
Bictegravir in the Elderly Living With HIV (BICEP)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Longer-Acting PrEP in Transgender and Gender Diverse Texans
- Status
- COMPLETED
- Phase
- N/A